US Patent

US10896751 — Storage and dispensing devices for administration of oral transmucosal dosage forms

Formulation · Assigned to AcelRx Pharmaceuticals Inc · Expires 2030-03-16 · 4y remaining

Vulnerability score 48/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects devices and systems for administering small volume oral transmucosal drug dosage forms, such as a single dose applicator or electromechanical device.

USPTO Abstract

Dispensing devices and systems for oral transmucosal administration of small volume drug dosage forms to the oral mucosa are provided. The dispensing device may be a single dose applicator (SDA), or an electromechanical device comprising a means for patient identification such as a wrist worn RFID tag and annular bidirectional antenna together with a lock-out feature.

Drugs covered by this patent

Patent Metadata

Patent number
US10896751
Jurisdiction
US
Classification
Formulation
Expires
2030-03-16
Drug substance claim
No
Drug product claim
Yes
Assignee
AcelRx Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.